Pharmaceutical Technology Europe
The potent nature of HPAPIs means there must be careful evaluation of the compound for its level of toxicity when considering manufacture.
Dave Bormett
Advertisement
Articles by Dave Bormett
Advertisement
Latest Updated Articles
- Let's talk the same language
October 1st 2008
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5